Search Result "TNFi biosimilar"

Export

Case Report
Development of Morphea Following Treatment with an ADA Biosimilar:A Case Report

Journal: Current Rheumatology Reviews

Volume: 20 Issue: 4 Year: 2024 Page: 451-454

Author(s): Aliki I. Venetsanopoulou,Paraskevi V. Voulgari,Alexandros A. Drosos

Industry News
Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar,Received FDA Approval for Treating Different Forms of Inflammato ryDiseases

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Volume: 22 Issue: 4 Year: 2023 Page: 273-275

Author(s): Vinod Kumar Rajana,Sudha Madhavi Penumaka

Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts

Journal: Current Drug Safety

Volume: 11 Issue: 1 Year: 2016 Page: 35-43

Author(s): E. Molinelli, A. Campanati, G. Ganzetti, A. Offidani

Mini-Review Article
Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

Journal: Current Rheumatology Reviews

Volume: 21 Issue: 0 Year: 2025 Page: 1-10

Author(s):

Biologic Drugs in Crohn's Disease and Ulcerative Colitis: Safety Profile

Journal: Current Drug Safety

Volume: 11 Issue: 1 Year: 2016 Page: 55-61

Author(s):

Utilization of Glycosylation Engineering in the Development of Therapeutic Proteins

Ebook: Recent Advances in Biotechnology

Volume: 3 Year: 2016

Author(s): Robert Yite Chou,Kevin B. Turner,Huijuan Li

Doi: 10.2174/9781681083919116030008

Pharmacotherapy for Inflammatory Processes

Ebook: Frontiers in Inflammation

Volume: 1 Year: 2016

Author(s): Graham A. Mackay,Alastair G. Stewart

Doi: 10.2174/9781681082271116010017

Research Article open access plus
Factors Associated with Axial Spondyloarthritis Remission in a Cohort of Saudi Patients with Longstanding Disease: A Multicenter ProspectiveCohort Study

Journal: Current Rheumatology Reviews

Volume: 21 Issue: 0 Year: 2025 Page: 1-11

Author(s): Abdulrahman Y Almansouri

Morpholine: Pharmacophore Modulating Pharmacokinetic Properties of Anticancer Leads

Ebook: Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II

Volume: 2 Year: 2022

Author(s):

Doi: 10.2174/9789815040043122020008

Mini-Review Article
A Complete Sojourn of Monoclonal Antibodies: AI, Rare Diseases / Disorders and Immunotoxic Effects

Journal: Current Proteomics

Volume: 21 Issue: 2 Year: 2024 Page: 58-78

Author(s):

Previous   Next

Go to   Results 1 - 1 of 12
Volume Years
Article Type
Publication Title
Subject Title
Content Type